Synthetic sunscreen ingredient (also known as Parsol 1789 and butyl methoxydibenzoylmethane) that can protect against the entire range of the sun’s UVA rays. It has been used since 1981 and is the most-used sunscreen ingredient in the world. It is the number one sunscreen agent used in Australian, Canadian, and European sunscreen formulations. In the United States, the FDA approved avobenzone’s use as a sunscreen agent only after more than seven years of study. Avobenzone had to meet scrupulous performance standards when Hoffman LaRoche applied for it to receive new drug status from the FDA. [1, 2]
New drug status is the most stringent FDA classification possible and requires more safety studies and efficacy substantiation than you can imagine.
- Amber K, Bloom R, Staropoli P, Dhiman S, Hu S. Assessing the Current Market of Sunscreen: A Cross-Sectional Study of Sunscreen Availability in Three Metropolitan Counties in the United States.. Journal of Skin Cancer.. 2014;2014:285357.
- Jansen R, Osterwalder U, Wang S, Burnett M, Lim H. Photoprotection: part II. Sunscreen: development, efficacy, and controversies. J Am Acad Dermatol.. 2013;69(6):867.e1-14.